Home › Funds › Stonepine Capital Management, LLC › ZVRA

Stonepine Capital Management, LLC position in ZVRA

ZEVRA THERAPEUTICS INC · Health Care

Stonepine Capital Management, LLC reported holding 100,000 shares of ZVRA (ZEVRA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.84% of its reported portfolio and ranking #30 among its reported holdings. Stonepine Capital Management, LLC has disclosed ZVRA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)100.00K sh
Reported value held$1.10M
Portfolio Weight0.84%
First reportedQ3 2024
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's ZVRA position evolved

Stonepine Capital Management, LLC first disclosed a stake in ZVRA in Q3 2024 at 700,000 shares (US$4.9M). The position peaked in Q3 2025 at 810,000 shares, worth US$7.7M. Across 9 filings, Stonepine Capital Management, LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 100,000 shares valued at US$1.1M — a reduction of -158,701 shares quarter over quarter.. Notable position changes include a 30% trim in Q4 2025 (shares rose 4% over the following quarter), a 46% trim in Q2 2026 (shares fell 24% over the following quarter), a 61% trim in Q3 2026 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 700.00K $4.86M New
Q4 2024 597.70K $4.98M Reduce
Q1 2025 650.00K $4.87M Add
Q2 2025 775.62K $6.83M Add
Q3 2025 810.00K $7.70M Add
Q4 2025 569.09K $5.10M Reduce
Q1 2026 480.00K $4.47M Reduce
Q2 2026 258.70K $3.71M Reduce
Q3 2026 100.00K $1.10M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZVRA and 13F data

ZVRA (ZEVRA THERAPEUTICS INC) is a Health Care company. 50 other funds we track also report a position in ZVRA — the largest reported positions include Nantahala Capital Management, LLC (US$21.5M), 683 Capital Management, LLC (US$12.3M), KINGDON CAPITAL MANAGEMENT, L.L.C. (US$11.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZVRA

All ZVRA fund holders →

FAQ

How long has Stonepine Capital Management, LLC held ZVRA?

Stonepine Capital Management, LLC has disclosed ZVRA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Stonepine Capital Management, LLC's current position in ZVRA?

As of Q3 2026, Stonepine Capital Management, LLC holds 100.00K shares of ZVRA (ZEVRA THERAPEUTICS INC), valued at $1.10M, representing 0.84% of its reported portfolio and ranking #30.

Has Stonepine Capital Management, LLC been buying or selling ZVRA?

In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC reduced its position in ZVRA. The position peaked in Q3 2025 at 810.00K shares.

Which other funds hold ZVRA?

Other major institutional holders of ZVRA include Nantahala Capital Management, LLC, 683 Capital Management, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.